Stock UK0MJFLSEHealthcareProfitless Growth

Ambu A/S(0MJF) Stock Analysis | Healthcare

DKK --+0.00%

Reward53Moderate

Risk45Moderate

50%Data

DKK —+0.00 (+0.00%) Previous close · LSE

Market cap 30.39Bn

Reward Ratingⓘ53 Moderate reward assessment · 50% data coverage

Bottom 50% of stocksView factors

Risk Ratingⓘ45 Moderate risk assessment

Risk factors availableUnlock details

Earnings & dividend markersEarnings Ex-dividend

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is Ambu A/S?

Ambu A/S, together with its subsidiaries, researches, develops, manufactures, markets, and sells medical technology solutions in North America, Europe, and internationally.

AI Brief Pro

The brief on Ambu A/S

The story behind the price, the case for and against, and what could go wrong. Open a part to read it.

What is Ambu A/S?

Ambu A/S, together with its subsidiaries, researches, develops, manufactures, markets, and sells medical technology solutions in North America, Europe, and internationally. The company offers endoscopy products, including bronchoscopes, video laryngoscopes, rhinolaryngoscopes, duodenoscopes, gastroscopes, cystoscopes, ureteroscopes, and displaying and processing units; neurology products, such as EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products; and cardiology products comprising ECG electrodes. The company is listed on the LSE in UK, operating in the Healthcare sector, with a market capitalisation of 30.39B, and a P/E ratio of 76.6x.